$2.2B
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | ABIVAX SA Abivax Sa | 1.8M | +29.5% | $240M | 11.0% |
| 2 | PTGX Protagonist Therapeutics Inc | 960,863 | −3.3% | $118M | 5.4% |
| 3 | ROIV Roivant Sciences Ltd | 3.2M | −3.9% | $112M | 5.1% |
| 4 | SPY State Str Spdr S&P 500 Etf T | 129,087 | +70.0% | $96M | 4.4% |
| 5 | IMVT Immunovant Inc | 2.3M | −13.0% | $90M | 4.1% |
| 6 | ZLAB Zai Lab Ltd | 3.4M | +136.4% | $64M | 2.9% |
| 7 | AGIO Agios Pharmaceuticals Inc | 1.3M | +815.6% | $48M | 2.2% |
| 8 | CRINETICS PHARMACEUTICALS IN Crinetics Pharmaceuticals In | 1.2M | +7.3% | $46M | 2.1% |
| 9 | EA SERIES TRUST Ea Series Trust | 337,125 | +0.0% | $39M | 1.8% |
| 10 | CYTK Cytokinetics Inc | 457,907 | −27.6% | $39M | 1.8% |
| 11 | SEPN Septerna Inc | 940,747 | −13.7% | $32M | 1.4% |
| 12 | AVR Anteris Technologies Global | 3.1M | −17.0% | $31M | 1.4% |
| 13 | EDIT Editas Medicine Inc | 8.9M | — | $29M | 1.3% |
| 14 | DNLI Denali Therapeutics Inc | 1.0M | −45.0% | $26M | 1.2% |
| 15 | SYRE Spyre Therapeutics Inc | 283,982 | −16.1% | $25M | 1.2% |
| 16 | VIR Vir Biotechnology Inc | 2.5M | −10.5% | $25M | 1.1% |
| 17 | PRAX Praxis Precision Medicines I | 74,253 | +4850.2% | $25M | 1.1% |
| 18 | INSM Insmed Inc | 228,520 | +545.7% | $24M | 1.1% |
| 19 | CLDX Celldex Therapeutics Inc New | 619,542 | +44.8% | $23M | 1.1% |
| 20 | VKTX Viking Therapeutics Inc | 574,038 | +152.1% | $22M | 1.0% |
| 21 | TSHA Taysha Gene Therapies Inc | 3.0M | +2.0% | $21M | 0.9% |
| 22 | MNPR Monopar Therapeutics Inc | 217,595 | −17.7% | $20M | 0.9% |
| 23 | OVID Ovid Therapeutics Inc | 7.4M | +63.2% | $20M | 0.9% |
| 24 | ELVN Enliven Therapeutics Inc | 387,718 | +17.7% | $20M | 0.9% |
| 25 | ENTA Enanta Pharmaceuticals Inc | 1.3M | +2518.0% | $20M | 0.9% |
| 26 | NKTR Nektar Therapeutics | 244,184 | +51.4% | $17M | 0.8% |
| 27 | INSPIRE MED SYS INC Inspire Med Sys Inc | 374,617 | −7.5% | $17M | 0.8% |
| 28 | RVMD Revolution Medicines Inc | 87,509 | −34.6% | $16M | 0.7% |
| 29 | ESTA Establishment Labs Hldgs Inc | 185,619 | −13.0% | $16M | 0.7% |
| 30 | PRTA Prothena Corp Plc | 1.6M | −1.7% | $15M | 0.7% |
| 31 | RYTM Rhythm Pharmaceuticals Inc | 136,158 | −35.6% | $15M | 0.7% |
| 32 | IKT Inhibikase Therapeutics Inc | 7.4M | +11.8% | $15M | 0.7% |
| 33 | UNIQURE NV Uniqure Nv | 324,672 | +326.0% | $15M | 0.7% |
| 34 | RLYB Rallybio Corp | 926,352 | +4411.1% | $15M | 0.7% |
| 35 | REGN Regeneron Pharmaceuticals | 22,208 | +82.7% | $14M | 0.6% |
| 36 | IVA Inventiva Sa | 3.6M | +65.9% | $14M | 0.6% |
| 37 | STRO Sutro Biopharma Inc | 404,014 | −23.0% | $13M | 0.6% |
| 38 | IONS Ionis Pharmaceuticals Inc | 166,286 | +3.7% | $13M | 0.6% |
| 39 | BBIO Bridgebio Pharma Inc | 176,689 | +87.4% | $13M | 0.6% |
| 40 | SRPT Sarepta Therapeutics Inc | 730,649 | +178.8% | $13M | 0.6% |
| 41 | CTMX Cytomx Therapeutics Inc. | 3.4M | −1.3% | $13M | 0.6% |
| 42 | VOR Vor Biopharma Inc | 680,626 | — | $13M | 0.6% |
| 43 | SPDR SERIES TRUST Spdr Series Trust | 135,585 | +0.0% | $12M | 0.6% |
| 44 | EQ Equillium Inc | 3.8M | +0.9% | $12M | 0.6% |
| 45 | ANL Adlai Nortye Ltd | 1.0M | +763.2% | $12M | 0.5% |
| 46 | CLYM Climb Bio Inc | 822,649 | +37.6% | $11M | 0.5% |
| 47 | HLXC Helix Acquisition Corp Iii | 1.0M | +0.0% | $11M | 0.5% |
| 48 | ZURA Zura Bio Ltd | 1.8M | +179.1% | $10M | 0.5% |
| 49 | OKUR Onkure Therapeutics Inc | 2.2M | −8.1% | $10M | 0.5% |
| 50 | MAZE Maze Therapeutics Inc | 339,276 | +577.3% | $10M | 0.5% |